Skip to main content
Top
Gepubliceerd in: Quality of Life Research 4/2009

01-05-2009

The precision of health state valuation by members of the general public using the standard gamble

Auteurs: Ken Stein, Matthew Dyer, Ruairidh Milne, Alison Round, Julie Ratcliffe, John Brazier

Gepubliceerd in: Quality of Life Research | Uitgave 4/2009

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Abstract

Background

Precision is a recognised requirement of patient-reported outcome measures but no previous studies of the precision of methods for obtaining health state values from the general public, based on specific health state descriptions or vignettes, have been carried out. The methodological requirements of policy makers internationally is driving growth in the use of methods to obtain utilities from the general public to inform cost per quality-adjusted life-year (QALY) analyses of health technologies being considered for adoption by health systems.

Methods

The precision of five comparisons of the outcomes of treatments, based on health state descriptions, was assessed against the results of clinical trials which showed a statistically and clinically significant improvement using an internet panel of members of the UK general public. Health states were developed to depict the baseline and post-treatment states from these exemplar clinical trials. Preferences for health states were obtained using bottom-up titrated standard gamble over the internet, and differences between summary health state values corresponding to the treatment and comparator groups within each exemplar study were compared. Results are considered in the context of various estimates for the minimally important difference in utility values.

Results

Participation among members of the internet panel in the five exemplars ranged from 27 to 59. In four of the five exemplars, the utility-based estimates of treatment benefit showed significant differences between groups and were greater than an assumed minimally important difference of 0.1. Mean utility differences between groups were: 0.23 (computerised cognitive behavioural therapy for depression, P < 0.001), 0.11 (hip resurfacing for hip osteoarthritis, P < 0.001), 0.0005 (cognitive behavioural therapy for insomnia, P = 0.98), 0.15 (pulmonary rehabilitation for COPD, P < 0.001) and 0.11 (infliximab for Crohn’s disease, P < 0.001). The confidence intervals around the estimates of utility-based treatment effect in three of the five examples did not exclude the possibility of a difference smaller than a minimally important difference of 0.1. Recent empirical evidence suggests a lower minimally important difference (0.03) may be more appropriate, in which case our results provide further reassurance of preservation of precision in health state description and valuation.

Conclusions

The precision of estimates of treatment effects based on preference data obtained from disease-specific measurements in clinically significant studies of health technologies was acceptable using an internet-based panel of members of the general public and the standard gamble. Definition of the minimally important difference in utility estimates is required to adequately assess precision and should be the subject of further research.
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
go back to reference Fitzpatrick, R., Davey, C., Buxton, M., & Jones, D. (1998). Evaluating patient based outcome measures for use in clinical trials. Health Technology Assessment, 2(14), i–iv. Fitzpatrick, R., Davey, C., Buxton, M., & Jones, D. (1998). Evaluating patient based outcome measures for use in clinical trials. Health Technology Assessment, 2(14), i–iv.
2.
go back to reference Kessler, R. C., & Mroczek, D. K. (1995). Measuring the effects of medical interventions. Medical Care, 33, AS109–AS119.PubMed Kessler, R. C., & Mroczek, D. K. (1995). Measuring the effects of medical interventions. Medical Care, 33, AS109–AS119.PubMed
3.
go back to reference Stewart, A. L. (1992). Conceptual and methodologic issues in defining quality of life: State of the art. Progress in Cardiovascular Nursing, 7, 3–11. Stewart, A. L. (1992). Conceptual and methodologic issues in defining quality of life: State of the art. Progress in Cardiovascular Nursing, 7, 3–11.
7.
go back to reference Stein, K., Dyer, M., Crabb, T., Milne, R., Round, A., Ratcliffe, J., & Brazier, J. (2006). An internet “value of health” panel: Recruitment, participation and compliance. Health and Quality of Life Outcomes, 4, 90. Stein, K., Dyer, M., Crabb, T., Milne, R., Round, A., Ratcliffe, J., & Brazier, J. (2006). An internet “value of health” panel: Recruitment, participation and compliance. Health and Quality of Life Outcomes, 4, 90.
12.
go back to reference Brazier, J., & Dolan, P. (2005). Evidence of preference construction in a comparison of variants of the standard gamble method. Health Economics and Decision Science Section Discussion Papers, University of Sheffield. Brazier, J., & Dolan, P. (2005). Evidence of preference construction in a comparison of variants of the standard gamble method. Health Economics and Decision Science Section Discussion Papers, University of Sheffield.
13.
go back to reference Lenert, L. A., & Sturley, A. E. (2002). Use of the internet to study the utility values of the public. In AMIA annual symposium proceedings (pp. 440–444). Lenert, L. A., & Sturley, A. E. (2002). Use of the internet to study the utility values of the public. In AMIA annual symposium proceedings (pp. 440–444).
14.
go back to reference Selmi, P. M., Klein, M. H., Greist, J. H., Sorrell, S. P., & Erdman, H. P. (1990). Computer-administered cognitive-behavioral therapy for depression. The American Journal of Psychiatry, 147, 51–56.PubMed Selmi, P. M., Klein, M. H., Greist, J. H., Sorrell, S. P., & Erdman, H. P. (1990). Computer-administered cognitive-behavioral therapy for depression. The American Journal of Psychiatry, 147, 51–56.PubMed
15.
go back to reference Beck, A. T., Rial, W. Y., & Rickels, K. (1974). Short form of depression inventory: Cross-validation. Psychological Reports, 34, 1184–1186.PubMed Beck, A. T., Rial, W. Y., & Rickels, K. (1974). Short form of depression inventory: Cross-validation. Psychological Reports, 34, 1184–1186.PubMed
17.
go back to reference Vale, L., Wyness, L., McCormack, K., McKenzie, L., Brazelli, M., & Stearns, S. (2001). Systematic review of the effectiveness and cost effectiveness of metal on metal hip resurfacing for treatment of hip disease. Health Services Research Unit, University of Aberdeen. Vale, L., Wyness, L., McCormack, K., McKenzie, L., Brazelli, M., & Stearns, S. (2001). Systematic review of the effectiveness and cost effectiveness of metal on metal hip resurfacing for treatment of hip disease. Health Services Research Unit, University of Aberdeen.
18.
go back to reference Morgan, K., Dixon, S., Mathers, N., Thompson, J., & Tomeny, M. (2004). Psychological treatment for insomnia in the regulation of long-term hypnotic drug use. Health Technology Assessment, 8, 1–94. Morgan, K., Dixon, S., Mathers, N., Thompson, J., & Tomeny, M. (2004). Psychological treatment for insomnia in the regulation of long-term hypnotic drug use. Health Technology Assessment, 8, 1–94.
20.
go back to reference Man, W. D., Polkey, M. I., Donaldson, N., Gray, B. J., & Moxham, J. (2004). Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: Randomised controlled study. BMJ (Clinical Research Ed.), 329, 1209. doi:10.1136/bmj.38258.662720.3A.CrossRef Man, W. D., Polkey, M. I., Donaldson, N., Gray, B. J., & Moxham, J. (2004). Community pulmonary rehabilitation after hospitalisation for acute exacerbations of chronic obstructive pulmonary disease: Randomised controlled study. BMJ (Clinical Research Ed.), 329, 1209. doi:10.​1136/​bmj.​38258.​662720.​3A.CrossRef
21.
go back to reference Lacasse, Y., Wong, E., & Guyatt, G. (1974). A systematic overview of the measurement properties of the chronic respiratory questionnaire. Canadian Respiratory Journal, 4, 131–139. Lacasse, Y., Wong, E., & Guyatt, G. (1974). A systematic overview of the measurement properties of the chronic respiratory questionnaire. Canadian Respiratory Journal, 4, 131–139.
22.
go back to reference Guyatt, G., Mitchell, A., Irvine, E. J., Singer, J., Williams, N., Goodacre, R., et al. (1989). A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology, 96, 804–810.PubMed Guyatt, G., Mitchell, A., Irvine, E. J., Singer, J., Williams, N., Goodacre, R., et al. (1989). A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology, 96, 804–810.PubMed
23.
24.
go back to reference Stein, K., & Milne, R. (1998). Health technology assessment. In M. Baker & S. Kirk (Eds.), Research and development in the NHS. Oxford: Radcliffe Medical. Stein, K., & Milne, R. (1998). Health technology assessment. In M. Baker & S. Kirk (Eds.), Research and development in the NHS. Oxford: Radcliffe Medical.
25.
go back to reference Williams, A. (1995). The measurement and valuation of health: A chronicle. University of York, York. Williams, A. (1995). The measurement and valuation of health: A chronicle. University of York, York.
26.
go back to reference Garside, R., Stein, K., Castelnuovo, E., Pitt, M., Aschcroft, D., Dimmock, P., et al. (2005). The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: A systematic review and economic evaluation. Health Technology Assessment, 9, 1–264. Garside, R., Stein, K., Castelnuovo, E., Pitt, M., Aschcroft, D., Dimmock, P., et al. (2005). The effectiveness and cost-effectiveness of pimecrolimus and tacrolimus for atopic eczema: A systematic review and economic evaluation. Health Technology Assessment, 9, 1–264.
27.
29.
go back to reference Brozek, J., Guyatt, G. H., & Schunemann, H. (2006). How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure. Health and Quality of Life Outcomes, 4, 69. Brozek, J., Guyatt, G. H., & Schunemann, H. (2006). How a well-grounded minimal important difference can enhance transparency of labelling claims and improve interpretation of a patient reported outcome measure. Health and Quality of Life Outcomes, 4, 69.
Metagegevens
Titel
The precision of health state valuation by members of the general public using the standard gamble
Auteurs
Ken Stein
Matthew Dyer
Ruairidh Milne
Alison Round
Julie Ratcliffe
John Brazier
Publicatiedatum
01-05-2009
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 4/2009
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-009-9446-6

Andere artikelen Uitgave 4/2009

Quality of Life Research 4/2009 Naar de uitgave